Physician profile
Mark H Strong
NPI 1902992118
$21,863.47
in general payments reported to CMS, 2019-2025
48 companies · $2,488 in 2025
The $2,488 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,756 · 2020: $1,712 · 2021: $3,283 · 2022: $4,609 · 2023: $2,638 · 2024: $3,378 · 2025: $2,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,503.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,625.85 | 2019-2025 | Aveir, Confirm Rx, Assurity |
| Pfizer INC. | $1,026.39 | 2019-2025 | |
| Philips North America LLC | $932.73 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, Mcot |
| Merck Sharp & Dohme LLC | $855.20 | 2021-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $660.90 | 2019-2024 | Xarelto |
| Amgen INC. | $534.37 | 2020-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $504.50 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $462.99 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $461.56 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Resonate El Icd Vr |
| Novartis Pharmaceuticals Corporation | $449.62 | 2019-2024 | |
| Medtronic, INC. | $443.22 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abiomed | $439.35 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $348.83 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $344.34 | 2019-2025 | Wainua, Farxiga, Lokelma |
| Sanofi-Aventis U.S. LLC | $311.34 | 2019-2024 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $283.53 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $279.03 | 2022-2025 | |
| Medtronic Vascular, INC. | $227.47 | 2019-2020 | |
| Astellas Pharma US INC | $209.03 | 2019-2022 | |
| Irhythm Technologies, INC. | $189.25 | 2019-2022 | |
| Edwards Lifesciences Corporation | $112.93 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Endologix LLC | $111.26 | 2020 | |
| Amarin Pharma, INC. | $101.28 | 2019-2021 | |
| Esperion Therapeutics, INC. | $82.39 | 2021-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $81.09 | 2019 | |
| Alnylam Pharmaceuticals INC. | $73.10 | 2025 | Amvuttra |
| Kowa Pharmaceuticals America, INC. | $60.29 | 2019-2022 | |
| Angiodynamics, INC. | $60.08 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $57.50 | 2022-2023 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $57.12 | 2023-2024 | Inpefa |
| Inspire Medical Systems, INC. | $53.22 | 2025 | Inspire |
| Silk Road Medical, INC. | $48.58 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $43.15 | 2019 | |
| Bridgebio Pharma, INC. | $41.96 | 2025 | Attruby |
| Gilead Sciences, INC. | $30.48 | 2019 | |
| Bardy Diagnostics, INC. | $30.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $29.47 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $23.32 | 2025 | Gore Cardioform Asd Occluder |
| Shockwave Medical, INC | $23.23 | 2021 | |
| Terumo Medical Corporation | $19.79 | 2024 | Glidewire |
| Atricure, INC. | $18.81 | 2023 | |
| Heartflow, INC. | $17.32 | 2024 | |
| Vifor Pharma, INC. | $17.03 | 2021 | |
| Scpharmaceuticals INC. | $16.81 | 2024 | |
| Baxter Healthcare | $16.65 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cvrx, INC. | $16.61 | 2025 | Barostim Neo System |
| Merit Medical Systems INC | $16.29 | 2023 | Laureate Hydrophilic Guide Wires |
| Preventice Services, LLC | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Strong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.